AFAP | Attenuert familiær adenomatøs polypose |
|---|---|
AFIP | Armed Forces Institute of Pathology |
antiTPO | Thyroideaperoxidase-antistoff |
ATA | American Thyroid Association |
ATC | Anaplastisk thyroideakarsinom |
BRAF | proto-oncogen B-Raf |
BTA | British Thyroid Association |
CEA | Carcinoembryonalt antigen |
CT | Computertomografi |
DTC | Differensiert thyroideakarsinom |
FAP | Familiær adenomatøs polypose |
FDG | Fluorodeoxyglucose |
FDOPA | Fluorodopa |
FNA(C) | Finnålsaspirasjonscytologi |
FNMTC | familiær ikke-medullært thyroideakarsinom |
FT3 | Fritt trijodtyronin |
FT4 | Fritt tyroksin |
MEN | Multippel endokrin neoplasi |
MR | Magnettomografi |
MTC | Medullær thyroidea cancer |
NaF | Natrium Fluorid (PET) |
NCI | National Cancer Institute |
NIFTP | noninvasiv follikulær thyroidea neoplasi med papillære kjerneforandringer |
PACS | Picture Archiving and Communication System |
PDTC | Poorly differentiated thyroid cancer |
PET | Positronemisjonstomografi |
proGRP | Pro-gastrin-releasing peptide |
PTC | Papillær thyroidea cancer |
PTH | Parathyroideahormon |
RET | reseptor tyrosin kinase proto-oncogene |
rhTSH | rekombinant humant thyroideastimulerende hormon |
RPMI-rør | Roswell Park Memorial Institute medium-rør |
SPECT | Single-photon emission computed tomography |
Tg | Thyroglobulin |
TRAS | TSH-reseptor-antistoff |
TSH | Thyroideastimulerende hormon |
TTF | Thyroid transcription factor |
UICC | Union internationale contre le cancer |
VUS | Variant med usikker betydning |
WBS | Whole body scan |
WHO | World Health Organization |